Latest Insider Transactions at Phathom Pharmaceuticals, Inc. (PHAT)
This section provides a real-time view of insider transactions for Phathom Pharmaceuticals, Inc. (PHAT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phathom Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phathom Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
13,900
-0.56%
|
$458,700
$33.05 P/Share
|
|
Aug 16
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
18,000
-0.71%
|
$540,000
$30.98 P/Share
|
|
Jul 07
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,609
-0.3%
|
$91,315
$35.05 P/Share
|
|
Jul 02
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.01 P/Share
|
|
Jul 01
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,226
-0.93%
|
$287,910
$35.16 P/Share
|
|
Jun 29
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
13,960
-1.1%
|
$474,640
$34.0 P/Share
|
|
Jun 28
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
26,040
-1.0%
|
$885,360
$34.58 P/Share
|
|
Jun 28
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
370
-0.04%
|
$12,950
$35.08 P/Share
|
|
Jun 25
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
24,131
-1.33%
|
$844,585
$35.76 P/Share
|
|
Jun 24
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,848
-1.18%
|
$379,680
$35.14 P/Share
|
|
Jun 23
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200
-0.02%
|
$7,000
$35.0 P/Share
|
|
Jun 22
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.0 P/Share
|
|
Jun 21
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,294
-1.0%
|
$325,290
$35.31 P/Share
|
|
Jun 18
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,398
-0.58%
|
$188,930
$35.13 P/Share
|
|
Jun 17
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,305
-0.35%
|
$115,675
$35.08 P/Share
|
|
Jun 14
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,826
-0.3%
|
$98,910
$35.06 P/Share
|
|
Jun 10
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,102
-0.22%
|
$73,570
$35.14 P/Share
|
|
Jun 09
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,191
-0.13%
|
$41,685
$35.28 P/Share
|
|
Jun 08
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.0 P/Share
|
|
Jun 07
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,264
-0.24%
|
$79,240
$35.05 P/Share
|
|
Jun 02
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,300
-0.45%
|
$150,500
$35.18 P/Share
|
|
Jun 01
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,211
-0.59%
|
$392,385
$35.88 P/Share
|
|
May 28
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,905
-0.31%
|
$320,580
$36.44 P/Share
|
|
May 27
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,453
-0.43%
|
$312,761
$37.27 P/Share
|
|
May 26
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,358
-0.63%
|
$444,888
$36.68 P/Share
|
|
May 25
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,947
-0.55%
|
$394,092
$36.38 P/Share
|
|
May 24
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,594
-0.52%
|
$370,790
$35.84 P/Share
|
|
May 21
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,648
-1.14%
|
$407,680
$35.74 P/Share
|
|
May 20
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,098
-0.69%
|
$248,430
$35.1 P/Share
|
|
May 20
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
3,482
-0.09%
|
$118,388
$34.65 P/Share
|
|
May 19
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
36,518
-0.92%
|
$1,168,576
$32.71 P/Share
|
|
May 14
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.0 P/Share
|
|
May 13
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100
-0.01%
|
$3,500
$35.33 P/Share
|
|
May 12
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,776
-0.57%
|
$412,160
$35.73 P/Share
|
|
May 07
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,011
-0.1%
|
$35,385
$35.03 P/Share
|
|
May 06
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
202
-0.02%
|
$7,070
$35.01 P/Share
|
|
May 05
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,936
-0.66%
|
$242,760
$35.14 P/Share
|
|
May 04
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
19,360
-0.46%
|
$696,960
$36.93 P/Share
|
|
May 04
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
4,457
-0.19%
|
$164,909
$37.03 P/Share
|
|
May 03
2021
|
Takeda Pharmaceutical CO LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,632
-0.45%
|
$556,016
$38.37 P/Share
|
|
May 03
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
10,043
-0.65%
|
$381,634
$38.22 P/Share
|
|
Apr 06
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
17,882
-0.33%
|
$643,752
$36.58 P/Share
|
|
Apr 05
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
22,118
-0.54%
|
$796,248
$36.41 P/Share
|
|
Apr 05
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
9,353
-0.4%
|
$336,708
$36.38 P/Share
|
|
Apr 01
2021
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
5,147
-0.32%
|
$190,439
$37.71 P/Share
|
|
Mar 22
2021
|
Terrie Curran President and Chief Executive |
SELL
Open market or private sale
|
Direct |
11,513
-95.05%
|
$495,059
$43.66 P/Share
|
|
Mar 22
2021
|
Terrie Curran President and Chief Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
11,513
+50.0%
|
$69,078
$6.95 P/Share
|
|
Mar 12
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
500
-0.04%
|
$23,000
$46.67 P/Share
|
|
Mar 11
2021
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
710,000
-18.56%
|
$30,530,000
$43.75 P/Share
|
|
Mar 11
2021
|
David A Socks |
SELL
Open market or private sale
|
Indirect |
42,429
-1.49%
|
$1,994,163
$47.36 P/Share
|